Our diligence process leverages the intellectual resources and insight of professionals across our limited partner base. In addition to financial return, opportunities are evaluated for fit with strategic priorities of our limited partner health systems and potential to improve clinical outcomes, reduce costs, and/or enhance the experience of patients, families, and caregivers.
Industry Venture and growth equity investments in healthcare information technology and services, and medical devices and diagnostics.
Investment Size Up to $10 million per round and $15 million per company.
Company Stage Early- to late-stage within three to five years of a potential liquidating event.
Adoption Potential Sustainable competitive advantage with compelling benefit sufficient to influence market adoption.
Management Team Established team with demonstrated relevant experience, depth and capability to build the business to scale and attract customers.
Other Ascension Ventures typically requests a Board seat or Board observation rights for each portfolio company.